Robert Kristal
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Robert Kristal
Earlier roles on record: CFO at BioRestorative Therapies, Inc. (BRTX) until July 13, 2026. BioRestorative Therapies, Inc. reported in an 8-K filed July 16, 2026 that Robert Kristal resigned as Chief Financial Officer, effective July 13, 2026. The proxy statement of BioRestorative Therapies, Inc. reports total compensation of $683,752 for Robert Kristal in fiscal 2024, including a base salary of $293,752. Disclosed compensation is on record for 4 fiscal years. Robert Kristal has spoken on 2 earnings calls across 1 company, most recently for BioRestorative Therapies, Inc. on May 14, 2025.
“On July 13, 2026, the Company received notices of resignation from (i) Lance Alstodt, as President, Chief Executive Officer and Chairman of the Board and, by the terms of his notice, from each other position he held as an officer or director of the Company, and (ii) Robert Kristal, as Chief Financial Officer of the Company and, by the terms of his notice, from each other position (if any) he held as an officer or director of the Company, in each case effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2026-07-13
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | BioRestorative Therapies, Inc. (BRTX) | Chief Financial Officer | $293,752 | $683,752 |
| 2023 | BioRestorative Therapies, Inc. (BRTX) | Chief Financial Officer | $240,624 | $618,124 |
| 2022 | BioRestorative Therapies, Inc. (BRTX) | Chief Financial Officer | $175,000 | $175,000 |
| 2021 | BioRestorative Therapies, Inc. (BRTX) | Chief Financial Officer | $29,166 | $82,383 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.